| # | Drug | Count |
|---|---|---|
| 0 | CAPECITABINE | 154 |
| 1 | OXALIPLATIN | 44 |
| 2 | FLUOROURACIL | 42 |
| 3 | FLUOROURACIL CREAM, 0.5% | 40 |
| 4 | TRASTUZUMAB | 15 |
| 5 | CISPLATIN | 14 |
| 6 | TUCATINIB | 9 |
| 7 | OCTREOTIDE ACETATE | 8 |
| 8 | BEVACIZUMAB | 7 |
| 9 | SIMVASTATIN | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | URIDINE TRIACETATE | 1 | 0.0067 |
| 1 | FLOXURIDINE | 1 | 0.0058 |
| 2 | CAPECITABINE | 154 | 0.0017 |
| 3 | DEXRAZOXANE FOR INJECTION | 1 | 0.0011 |
| 4 | CLEMASTINE FUMARATE | 1 | 0.0007 |
| 5 | OXALIPLATIN | 44 | 0.0006 |
| 6 | MITOMYCIN | 2 | 0.0005 |
| 7 | FLUOROURACIL | 42 | 0.0005 |
| 8 | FLUOROURACIL CREAM, 0.5% | 40 | 0.0005 |
| 9 | MANNITOL | 2 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Somatostatin Analog [EPC] | 6 | 0.0009 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 190 | 0.0007 |
| 2 | Osmotic Diuretic [EPC] | 2 | 0.0004 |
| 3 | Platinum-based Drug [EPC] | 60 | 0.0002 |
| 4 | HER2/neu Receptor Antagonist [EPC] | 15 | 0.0002 |
| 5 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 6 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 7 | Polyene Antifungal [EPC] | 3 | 0.0001 |
| 8 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |
| 9 | Microtubule Inhibitor [EPC] | 7 | 0.0000 |